These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 24663151)

  • 1. The 2.1 Å resolution structure of cyanopindolol-bound β1-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor.
    Miller-Gallacher JL; Nehmé R; Warne T; Edwards PC; Schertler GF; Leslie AG; Tate CG
    PLoS One; 2014; 9(3):e92727. PubMed ID: 24663151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a beta1-adrenergic G-protein-coupled receptor.
    Warne T; Serrano-Vega MJ; Baker JG; Moukhametzianov R; Edwards PC; Henderson R; Leslie AG; Tate CG; Schertler GF
    Nature; 2008 Jul; 454(7203):486-91. PubMed ID: 18594507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor.
    Sato T; Baker J; Warne T; Brown GA; Leslie AG; Congreve M; Tate CG
    Mol Pharmacol; 2015 Dec; 88(6):1024-34. PubMed ID: 26385885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.
    Isogai S; Deupi X; Opitz C; Heydenreich FM; Tsai CJ; Brueckner F; Schertler GF; Veprintsev DB; Grzesiek S
    Nature; 2016 Feb; 530(7589):237-41. PubMed ID: 26840483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of β-arrestin coupling to formoterol-bound β
    Lee Y; Warne T; Nehmé R; Pandey S; Dwivedi-Agnihotri H; Chaturvedi M; Edwards PC; García-Nafría J; Leslie AGW; Shukla AK; Tate CG
    Nature; 2020 Jul; 583(7818):862-866. PubMed ID: 32555462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into conformational stability of wild-type and mutant beta1-adrenergic receptor.
    Balaraman GS; Bhattacharya S; Vaidehi N
    Biophys J; 2010 Jul; 99(2):568-77. PubMed ID: 20643076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed mutagenesis of the rat beta1-adrenoceptor. Involvement of Tyr356 (7.43) in (+/-)cyanopindolol but not (+/-)[125Iodo]cyanopindolol binding.
    Rezmann-Vitti LA; Louis SN; Nero TL; Jackman GP; Machida CA; Louis WJ
    Eur J Med Chem; 2004 Jul; 39(7):625-31. PubMed ID: 15236843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Pressure Shifts the β
    Abiko LA; Grahl A; Grzesiek S
    J Am Chem Soc; 2019 Oct; 141(42):16663-16670. PubMed ID: 31564099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering an ultra-thermostable β(1)-adrenoceptor.
    Miller JL; Tate CG
    J Mol Biol; 2011 Oct; 413(3):628-38. PubMed ID: 21907721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.
    Baker JG; Proudman RG; Tate CG
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
    Warne T; Moukhametzianov R; Baker JG; Nehmé R; Edwards PC; Leslie AG; Schertler GF; Tate CG
    Nature; 2011 Jan; 469(7329):241-4. PubMed ID: 21228877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.
    Baker JG; Proudman RG; Hill SJ
    Mol Pharmacol; 2014 May; 85(5):811-29. PubMed ID: 24608857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early expression of a beta1-adrenergic receptor and catecholamines in Xenopus oocytes and embryos.
    Devic E; Paquereau L; Steinberg R; Caput D; Audigier Y
    FEBS Lett; 1997 Nov; 417(2):184-90. PubMed ID: 9395292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.
    Warne T; Edwards PC; Leslie AG; Tate CG
    Structure; 2012 May; 20(5):841-9. PubMed ID: 22579251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPCR Activation States Induced by Nanobodies and Mini-G Proteins Compared by NMR Spectroscopy.
    Rößler P; Mayer D; Tsai CJ; Veprintsev DB; Schertler GFX; Gossert AD
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33348734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation.
    Gherbi K; May LT; Baker JG; Briddon SJ; Hill SJ
    FASEB J; 2015 Jul; 29(7):2859-71. PubMed ID: 25837585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational plasticity of ligand-bound and ternary GPCR complexes studied by
    Frei JN; Broadhurst RW; Bostock MJ; Solt A; Jones AJY; Gabriel F; Tandale A; Shrestha B; Nietlispach D
    Nat Commun; 2020 Feb; 11(1):669. PubMed ID: 32015348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
    Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
    Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.